TELA Bio, Inc. SEC filings TELA

TELA Bio, Inc. has 545 filings in SEC EDGAR's recent list, going back to Dec 6, 2012. Its latest annual report, Form ARS, was filed on Apr 30, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 8, 2026 (shareholder vote results). The company's fiscal year ends on December 31.

TELA Bio, Inc. SEC filings
Form Description Filed Period
4 Insider transaction Oct 19, 2026 Oct 15, 2026
4 Insider transaction Oct 19, 2026 Oct 15, 2026
8-K Current report
Shareholder vote results
Oct 8, 2026 Oct 8, 2026
8-K Current report
Other events
Oct 6, 2026 Oct 5, 2026
8-K Current report
Other events
Oct 5, 2026 Oct 5, 2026
8-K Current report
Material agreement
Sep 29, 2026 Sep 28, 2026
4 Insider transaction Sep 18, 2026 Sep 16, 2026
8-K Current report
Listing notice
Sep 18, 2026 Sep 15, 2026
4 Insider transaction Sep 16, 2026 Sep 14, 2026
DEF 14A Proxy statement Sep 14, 2026 Oct 8, 2026
PRE 14A Preliminary proxy statement Sep 4, 2026 Oct 8, 2026
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure
Aug 31, 2026 Aug 28, 2026
4 Insider transaction Aug 19, 2026 Aug 17, 2026
4 Insider transaction Aug 17, 2026 Aug 14, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2026 —
8-K/A Amended current report
Officer or director change
Aug 13, 2026 Aug 3, 2026
S-8 Employee stock plan registration Aug 11, 2026 —
10-Q Quarterly report Aug 11, 2026 Jun 30, 2026
SCHEDULE 13G Ownership over 5% (passive) Aug 11, 2026 —
8-K Current report
Results of operations
Aug 10, 2026 Aug 10, 2026
4 Insider transaction Aug 5, 2026 Aug 3, 2026
3 Initial insider ownership Aug 5, 2026 Aug 3, 2026
S-8 Employee stock plan registration Aug 4, 2026 —
8-K Current report
Officer or director change
Aug 4, 2026 Aug 3, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jul 17, 2026 Jul 15, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
3 Initial insider ownership Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
3 Initial insider ownership Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
3 Initial insider ownership Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
3 Initial insider ownership Jun 11, 2026 Jun 9, 2026
4 Insider transaction Jun 11, 2026 Jun 9, 2026
8-K Current report
Officer or director change, Shareholder vote results
Jun 11, 2026 Jun 9, 2026
SCHEDULE 13D Ownership over 5% (active) Jun 9, 2026 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
10-Q Quarterly report May 13, 2026 Mar 31, 2026
8-K Current report
Results of operations, Regulation FD disclosure
May 12, 2026 May 12, 2026
ARS Annual report to shareholders Apr 30, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 30, 2026 —
DEF 14A Proxy statement Apr 30, 2026 Jun 9, 2026
8-K Current report
Results of operations, Officer or director change
Apr 30, 2026 Apr 29, 2026
S-8 Employee stock plan registration Mar 25, 2026 —
10-K Annual report Mar 25, 2026 Dec 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Mar 24, 2026 Mar 24, 2026
8-K Current report
Listing notice
Mar 20, 2026 Mar 17, 2026
3 Initial insider ownership Mar 11, 2026 Mar 1, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 20, 2026
4 Insider transaction Feb 24, 2026 Feb 18, 2026
424B3 Prospectus Dec 23, 2025 —
EFFECT Filing Dec 18, 2025 —
CORRESP Letter to the SEC Dec 16, 2025 —
S-3 Shelf registration Dec 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 17, 2025 —
4 Insider transaction Nov 17, 2025 Nov 17, 2025
8-K Current report
Material agreement, Agreement ended, New debt, Unregistered share sale
Nov 14, 2025 Nov 13, 2025
424B5 Prospectus supplement Nov 14, 2025 —
10-Q Quarterly report Nov 14, 2025 Sep 30, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Nov 14, 2025 —
424B5 Prospectus supplement Nov 13, 2025 —
8-K Current report
Results of operations, Regulation FD disclosure
Nov 13, 2025 Nov 13, 2025
4 Insider transaction Nov 3, 2025 Oct 31, 2025
3 Initial insider ownership Nov 3, 2025 Oct 31, 2025
8-K Current report
Officer or director change
Nov 3, 2025 Oct 31, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Oct 15, 2025 —
4 Insider transaction Oct 10, 2025 Oct 9, 2025
3 Initial insider ownership Oct 10, 2025 Oct 9, 2025
8-K Current report
Officer or director change
Oct 9, 2025 Oct 4, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
S-8 Employee stock plan registration Aug 11, 2025 —
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations, Regulation FD disclosure
Aug 11, 2025 Aug 11, 2025
4 Insider transaction Aug 5, 2025 Aug 3, 2025
4 Insider transaction Jun 2, 2025 Jun 2, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Jun 2, 2025 May 30, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
4 Insider transaction May 30, 2025 May 28, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 30, 2025 May 28, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 30, 2025 —
SCHEDULE 13G Ownership over 5% (passive) May 30, 2025 —
10-Q Quarterly report May 8, 2025 Mar 31, 2025
8-K Current report
Results of operations, Regulation FD disclosure
May 8, 2025 May 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) May 8, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) May 7, 2025 —
ARS Annual report to shareholders Apr 17, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 17, 2025 —
DEF 14A Proxy statement Apr 17, 2025 May 28, 2025
PRE 14A Preliminary proxy statement Apr 7, 2025 May 28, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
4 Insider transaction Apr 2, 2025 Mar 31, 2025
8-K Current report
Other events
Mar 31, 2025 Mar 31, 2025
S-8 Employee stock plan registration Mar 21, 2025 —
10-K Annual report Mar 21, 2025 Dec 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Mar 20, 2025 Mar 20, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 25, 2025 Feb 21, 2025
4 Insider transaction Feb 21, 2025 Feb 19, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 14, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Feb 13, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Feb 12, 2025 —
SCHEDULE 13G/A Amended ownership over 5% (passive) Jan 31, 2025 —
SCHEDULE 13G Ownership over 5% (passive) Nov 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Nov 14, 2024 —
10-Q Quarterly report Nov 8, 2024 Sep 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Nov 7, 2024 Nov 7, 2024
SC 13G Ownership over 5% (passive) Oct 29, 2024 —
SC 13G/A Amended ownership over 5% (passive) Oct 28, 2024 —
SC 13D/A Amended ownership over 5% (active) Oct 25, 2024 —
4 Insider transaction Oct 24, 2024 Oct 24, 2024
4 Insider transaction Oct 24, 2024 Oct 24, 2024
4 Insider transaction Oct 24, 2024 Oct 24, 2024
4 Insider transaction Oct 24, 2024 Oct 24, 2024
8-K Current report
Material agreement
Oct 23, 2024 Oct 23, 2024
424B5 Prospectus supplement Oct 23, 2024 —
424B5 Prospectus supplement Oct 22, 2024 —
8-K Current report
Results of operations, Regulation FD disclosure
Oct 22, 2024 Oct 22, 2024
SC 13D/A Amended ownership over 5% (active) Oct 1, 2024 —
10-Q Quarterly report Aug 13, 2024 Jun 30, 2024
8-K Current report
Results of operations, Regulation FD disclosure
Aug 12, 2024 Aug 12, 2024
4 Insider transaction Aug 6, 2024 Aug 3, 2024
SCHEDULE 13G Ownership over 5% (passive) Jul 30, 2024 —
SC 13G Ownership over 5% (passive) Jul 22, 2024 —
SC 13D/A Amended ownership over 5% (active) Jul 2, 2024 —
4 Insider transaction Jul 2, 2024 Jun 28, 2024
144 Notice of proposed sale Jun 28, 2024 —
SC 13G/A Amended ownership over 5% (passive) Jun 10, 2024 —
4 Insider transaction Jun 6, 2024 Jun 4, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
4 Insider transaction Jun 6, 2024 Jun 4, 2024
3 Initial insider ownership Jun 6, 2024 Jun 4, 2024
8-K Current report
Officer or director change, Shareholder vote results, Other events
Jun 6, 2024 Jun 4, 2024
8-K Current report
Other events
May 20, 2024 May 19, 2024
10-Q Quarterly report May 10, 2024 Mar 31, 2024
8-K Current report
Results of operations, Regulation FD disclosure
May 9, 2024 May 9, 2024
ARS Annual report to shareholders Apr 18, 2024 Dec 31, 2023
DEFA14A Additional proxy material Apr 18, 2024 —
DEF 14A Proxy statement Apr 18, 2024 Jun 4, 2024
8-K Current report
Other events
Apr 15, 2024 Apr 15, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
4 Insider transaction Apr 2, 2024 Mar 31, 2024
S-8 Employee stock plan registration Mar 22, 2024 —
10-K Annual report Mar 22, 2024 Dec 31, 2023
8-K Current report
Results of operations, Regulation FD disclosure, Other events
Mar 21, 2024 Mar 21, 2024
8-K Current report
Other events
Mar 20, 2024 Mar 15, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 27, 2024 Feb 23, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 23, 2024 Feb 21, 2024
4 Insider transaction Feb 16, 2024 Apr 1, 2020
3/A Filing Feb 16, 2024 Mar 31, 2020
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G Ownership over 5% (passive) Feb 14, 2024 —
SC 13G/A Amended ownership over 5% (passive) Feb 7, 2024 —
4 Insider transaction Dec 7, 2023 Dec 5, 2023
EFFECT Filing Nov 20, 2023 —
CORRESP Letter to the SEC Nov 16, 2023 —
UPLOAD Letter from the SEC Nov 16, 2023 —
4 Insider transaction Nov 14, 2023 Nov 14, 2023
4 Insider transaction Nov 14, 2023 Nov 14, 2023
S-3 Shelf registration Nov 13, 2023 —
10-Q Quarterly report Nov 13, 2023 Sep 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Nov 9, 2023 Nov 9, 2023
8-K Current report
Material agreement
Oct 20, 2023 Oct 18, 2023
SC 13G Ownership over 5% (passive) Oct 6, 2023 —
8-K Current report
Officer or director change
Sep 28, 2023 Sep 22, 2023
8-K Current report
Other events
Aug 16, 2023 Aug 16, 2023
10-Q Quarterly report Aug 10, 2023 Jun 30, 2023
8-K Current report
Results of operations, Regulation FD disclosure
Aug 9, 2023 Aug 9, 2023
4 Insider transaction Aug 4, 2023 Aug 3, 2023
3 Initial insider ownership Aug 4, 2023 Aug 3, 2023
4 Insider transaction Jun 2, 2023 Jun 1, 2023
4 Insider transaction Jun 2, 2023 Jun 1, 2023
4 Insider transaction Jun 2, 2023 Jun 1, 2023

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
TELA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Malvern, PA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1561921

Other Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.